NEWS
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, has received notice of delisting from Nasdaq due to non-compliance with the minimum stockholder's equity requirement. The company's common stock will be suspended from trading on Nasdaq effective October 16, 2024, and is expected to begin trading on the OTCQB on the same date.
The Nasdaq Hearings Panel had previously given Seelos until October 11, 2024, to regain compliance with the Equity Standard Rule. However, the company failed to meet this requirement. Seelos cautions that there is no assurance that a broker will continue to make a market in the company's common stock or that trading will continue on an over-the-counter market or elsewhere.
The Nasdaq Hearings Panel had previously given Seelos until October 11, 2024, to regain compliance with the Equity Standard Rule. However, the company failed to meet this requirement. Seelos cautions that there is no assurance that a broker will continue to make a market in the company's common stock or that trading will continue on an over-the-counter market or elsewhere.
免責事項：このコミュニティは、Moomoo Technologies Inc.が教育目的でのみ提供するものです。
さらに詳しい情報
コメント
サインインコメントをする
Spread kindness and love. Life is short. Don’t let greed eat you.
2478フォロワー
107フォロー中
27K訪問者
フォロー
吃瓜群众代表 : otcマーケットは何ですか？
XingYe 吃瓜群众代表 : OTCは店頭取引を示し、意味はペニーストックを指します。
烟雨朦胧 XingYe : この株をまだ中立する必要がありますか、すでにほとんど損失しています